Basal-Bolus Insulin Therapy

---

ONLINEBBI

Wednesday, August 25, 2021, 12:00 AM - Saturday, August 24, 2024, 11:59 PM


AMA PRA Category 1 Credits™ (1.00 hours), ACPE Contact Hour(s) (1.00 hours), ANCC - Nursing Contact Hour(s) (1.00 hours), Non-Physician Attendance (1.00 hours)

Adequate glycemic control in patients with or without diabetes is an essential aspect of overall of cancer care. Hyperglycemia during hospitalization is associated with increased risk of complications and extended hospital stay. This module is designed to introduce basal-bolus insulin therapy as the standard of treatment for inpatient hyperglycemia. The module focuses on the foundational concepts of basal-bolus insulin therapy which include: components of BBI, advantages of BBI over sliding scale insulin (SSI), and collaborative care strategies in the care of patients with hyperglycemia in the inpatient settings.

1. Identify the advantages of basal-bolus insulin therapy over sliding scale insulin.
2. Identify the components of basal-bolus insulin therapy.
3. Summarize the collaborative care strategies in the prevention and management of hyperglycemia.

This activity is no longer active. CE credit has expired.

 

Registration: Free
Release Date: August 25, 2021
Expiration Date: August 25, 2024
Estimated time to complete:  60 minutes

 

Requirements for Successful Activity Completion:
After reviewing the activity information and the faculty disclosure, then follow these steps to successful completion:
View the video recording in its entirety
Complete the learning assessments within the activity
Complete the post-test
Submit the activity evaluation

Pharmacists must provide their NABP e-Profile ID and date of birth (MMDD).
Pharmacists - Continuing Pharmacy Education (CPE) credit for this activity will only be awarded via CPE monitor. Credit will be submitted to CPE monitor within 60 days from activity completion.

Content:
Please click on the Education Center link to be re-directed to the Education Center and prompted to login. 
Once logged in, type in Basal-Bolus Insulin Therapy in the search bar to locate the activity. 

Education Center

In support of improving patient care, The University of Texas MD Anderson Cancer Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

View the accessibility policy for The University of Texas M.D Anderson Cancer Center.

 

The University of Texas MD Anderson Cancer Center complies with all requirements of the identified accrediting body  (ACCME, ANCC, ACPE). Disclosure of speakers, faculty members, planning committee members and their commercial relationships will be shared with learners prior to the educational activity.

Mitigation of Relevant Financial Relationships

The University of Texas MD Anderson Cancer Center adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

No commercial support was provided.